William Blair initiated coverage on FibroGen (NASDAQ: FGEN) with an Outperform rating.Analyst John Sonnier estimated that the company would generate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE